These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Comparison of pharmaceutical abatement in various water matrices by conventional ozonation, peroxone (O3/H2O2), and an electro-peroxone process. Author: Wang H, Zhan J, Yao W, Wang B, Deng S, Huang J, Yu G, Wang Y. Journal: Water Res; 2018 Mar 01; 130():127-138. PubMed ID: 29216480. Abstract: Pharmaceutical abatement in a groundwater (GW), surface water (SW), and secondary effluent (SE) by conventional ozonation, the conventional peroxone (O3/H2O2), and the electro-peroxone (E-peroxone) processes was compared in batch tests. SE had significantly more fast-reacting dissolved organic matter (DOM) moieties than GW and SW. Therefore, O3 decomposed much faster in SE than in GW and SW. At specific ozone doses of 0.5-1.5 mg O3/mg dissolved organic carbon (DOC), the application of O3/H2O2 and E-peroxone process (by adding external H2O2 stocks or in-situ generating H2O2 from cathodic O2 reduction during ozonation) similarly enhanced the OH yield from O3 decomposition by ∼5-12% and 5-7% in GW and SW, respectively, compared to conventional ozonation. In contrast, due to the slower reaction kinetics of O3 with H2O2 than O3 with fast-reacting DOM moieties, the addition or electro-generation of H2O2 hardly increased the OH yield (<4% increases) in SE. Corresponding to the changes in the OH yields, the abatement efficiencies of ozone-resistant pharmaceuticals (ibuprofen and clofibric acid) increased evidently in GW (up to ∼14-18% at a specific ozone dose of 1.5 mg O3/mg DOC), moderately in SW (up to 6-10% at 0.5 mg O3/mg DOC), and negligibly in SE during the O3/H2O2 and E-peroxone treatment compared to conventional ozonation. These results indicate that similar to the conventional O3/H2O2 process, the E-peroxone process can more pronouncedly enhance O3 transformation to OH, and thus increase the abatement efficiency of ozone-resistant pharmaceuticals in water matrices exerting relatively high ozone stability (e.g., groundwater and surface water with low DOM contents). Therefore, by installing electrodes in existing ozone reactors, the E-peroxone process may provide a convenient way to enhance pharmaceutical abatement in drinking water applications, where groundwater and surface water with low DOM contents are used as the source waters.[Abstract] [Full Text] [Related] [New Search]